Adherence to treatment regimen and bleeding rates in a prospective cohort of youth and young adults on low-dose daily prophylaxis for severe hemophilia A
Crossref DOI link: https://doi.org/10.1186/s12878-016-0067-3
Published Online: 2016-11-08
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mizrahi, Terry
St-Louis, Jean
Young, Nancy L.
Ménard, Francine
Zourikian, Nichan
Dubé, Evemie
Rivard, Georges E.
Funding for this research was provided by:
Bayer Canada
Pfizer Canada.
License valid from 2016-11-08